Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -4 of 4
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
10/14/2008
 
First Published:
7/14/2006
1.
Phase I/II Pilot Study of Ifosfamide, Carboplatin, Etoposide, and Monoclonal Antibody SGN-30 in Pediatric Patients With CD30-Positive Recurrent Anaplastic Large Cell Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Active
1 to 21
NCI
COG-ANHL06P1
ANHL06P1, NCT00354107
2.
Study of SGN-30 (Antibody) in Patients with Refractory or Recurrent Hodgkin's Disease or Anaplastic Large Cell Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
Pharmaceutical / Industry
SG030-0003
NCT00079755
3.
Study of SGN-30 (anti-CD30 mAb) in Patients with Primary Cutaneous Anaplastic Large Cell Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
Pharmaceutical / Industry
SG030-0004
NCT00099255
Last Modified:
9/25/2006
 
First Published:
8/13/2006
4.
Phase II Study of Monoclonal Antibody SGN-30 in Combination With Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone in Patients With Newly Diagnosed Anaplastic Large Cell Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
NCI
MDA-2005-0627
7372, NCI-7372, NCT00365274
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute